Zobrazeno 1 - 10
of 56
pro vyhledávání: '"T A Wadden"'
Publikováno v:
Obesity Science & Practice, Vol 5, Iss 4, Pp 342-353 (2019)
Summary Objective Weight bias internalization (WBI) is associated with poor weight‐related health. The purpose of this study was to identify the prevalence and correlates of WBI in a large sample of adults in a commercial weight management programm
Externí odkaz:
https://doaj.org/article/99b7226283ad40b6a13058d3773d78c0
Autor:
J. Rushing, R. Wing, T. A. Wadden, W. C. Knowler, M. Lawlor, M. Evans, T. Killean, M. Montez, M. A. Espeland, P. Zhang, The Look AHEAD Research Group
Publikováno v:
Obesity Science & Practice, Vol 3, Iss 1, Pp 15-24 (2017)
Summary Objective The Action for Health in Diabetes (Look AHEAD) trial was a randomized controlled clinical trial to compare the effects of 10 years of intensive lifestyle intervention (ILI) with a control condition of diabetes support and education
Externí odkaz:
https://doaj.org/article/e85fe9cf02d54ad782f17d45a950ab32
Autor:
A M, Chao, T A, Wadden, R L, Pearl, N, Alamuddin, S M, Leonard, Z M, Bakizada, E, Pinkasavage, K A, Gruber, O A, Walsh, R I, Berkowitz, N, Alfaris, J S, Tronieri
Publikováno v:
Clinical obesity. 8(6)
Antiobesity medication may help people maintain diet-induced reductions in appetite. The present exploratory analysis assessed the effects of lorcaserin on changes at 24 weeks post-randomization in emotion- and stress-related eating, food cravings, a
Publikováno v:
Clinical obesity. 8(2)
Weight discrimination affects a significant proportion of individuals with obesity and contributes to poor mental and physical health. Prior research on weight discrimination has been limited by a lack of racial diversity in samples, and has not cons
Autor:
T A, Wadden, P, Hollander, S, Klein, K, Niswender, V, Woo, P M, Hale, L, Aronne, Sean, Wharton
Publikováno v:
International Journal of Obesity. 37:1443-1451
Liraglutide, a once-daily human glucagon-like peptide-1 analog, induced clinically meaningful weight loss in a phase 2 study in obese individuals without diabetes. The present randomized phase 3 trial assessed the efficacy of liraglutide in maintaini
Autor:
W. C. Gross, L. K. Khan, J. S. Stern, R. Weinsier, R. Cleland, V. Hubbard, M. Daynard, T. A. Wadden, D. C. Graybill, S. Yanovski
Publikováno v:
Critical Reviews in Food Science and Nutrition. 41:45-70
Autor:
T. A. Wadden
Publikováno v:
Journal of Clinical Endocrinology & Metabolism. 83:214-218
Publikováno v:
Obesity reviews : an official journal of the International Association for the Study of Obesity. 12(5)
Obesity may lead to depression or be one of its consequences. We reviewed population-based studies in order to, first, identify the most commonly used research methods, and, second, to evaluate the strength of evidence for prospective associations am
Autor:
T. A. Wadden
Publikováno v:
Archives of Internal Medicine. 152:961-966
Autor:
T A, Wadden
Publikováno v:
Postgraduate medicine. 109
A variety of treatments--behavior-modification programs, reduced-calorie diets, and pharmacotherapy--are available to treat obesity and can be effective in producing the 5% to 10% weight loss now recommended as a primary goal of therapy. The mechanis